Phage Display Technology and its Applications in Cancer Immunotherapy

Anticancer Agents Med Chem. 2019;19(2):229-235. doi: 10.2174/1871520618666181029140814.

Abstract

Background: Phage display is an effective technology for generation and selection targeting protein for a variety of purpose, which is based on a direct linkage between the displayed protein and the DNA sequence encoding it and utilized in selecting peptides, improving peptides affinity and indicating protein-protein interactions. Phage particles displaying peptide have the potential to apply in the identification of cell-specific targeting molecules, identification of cancer cell surface biomarkers, identification anti-cancer peptide, and the design of peptide-based anticancer therapy.

Method/results: Literature searches, reviews and assessments about Phage were performed in this review from PubMed and Medline databases.

Conclusion: The phage display technology is an inexpensive method for expressing exogenous peptides, generating unique peptides that bind any given target and investigating protein-protein interactions. Due to the powerful ability to insert exogenous gene and display exogenous peptides on the surface, phages may represent a powerful peptide delivery system that can be utilized to develop rapid, efficient, safe and inexpensive cancer therapy methods.

Keywords: Phage; anti-cancer; cancer; immunotherapy; protein targeting; protein-protein interactions..

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cell Surface Display Techniques*
  • Humans
  • Immunotherapy*
  • Neoplasms / immunology
  • Neoplasms / therapy*
  • Peptides / chemistry
  • Peptides / genetics*

Substances

  • Peptides